← Browse by Condition
Medical Condition

newly diagnosed

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 4

ClinicalMetric tracks all active clinical trials for newly diagnosed sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — newly diagnosed Clinical Trials

How many clinical trials are currently recruiting for newly diagnosed?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for newly diagnosed, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for newly diagnosed?
newly diagnosed research spans Phase 2 (3 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a newly diagnosed clinical trial?
Eligibility criteria for newly diagnosed trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
3
Phase 4
1
Top Sponsors
The First Affiliated Hospital of Soochow University 1 trial
Fujian Medical University Union Hospital 1 trial
The First Affiliated Hospital of Xiamen University 1 trial
Chinese PLA General Hospital 1 trial

Recruiting Clinical Trials

NCT06532552 Phase 2
Recruiting
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
Enrollment
172 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT07561892 Phase 4
Recruiting
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).
Enrollment
100 pts
Location
China
Sponsor
Fujian Medical University Unio...
View Trial →
NCT06553352 Phase 2
Recruiting
Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma
Enrollment
39 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT05833893 Phase 2
Recruiting
Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma
Enrollment
10 pts
Location
China
Sponsor
Chinese PLA General Hospital
View Trial →

Related Conditions

acute myeloid leukemia adult (1) acute myeloid leukemia (1) chemotherapy effect (1) follicular lymphoma (1) nk t cell lymphoma (1) advanced lymphoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology